|
1
|
Sagoo MK and Gnudi L: Diabetic
nephropathy: An overview. Methods Mol Biol. 2067:3–7.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Gheith O, Farouk N, Nampoory N, Halim MA
and Al-Otaibi T: Diabetic kidney disease: World wide difference of
prevalence and risk factors. J Nephropharmacol. 5:49–56.
2016.PubMed/NCBI
|
|
3
|
Szrejder M and Piwkowska A: AMPK
signalling: Implications for podocyte biology in diabetic
nephropathy. Biol Cell. 111:109–120. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Eftekhari A, Vahed SZ, Kavetskyy T,
Rameshrad M, Jafari S, Chodari L, Hosseiniyan SM, Derakhshankhah H,
Ahmadian E and Ardalan M: Cell junction proteins: Crossing the
glomerular filtration barrier in diabetic nephropathy. Int J Biol
Macromol. 148:475–482. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
An X, Zhang L, Yuan Y, Wang B, Yao Q, Li L
and Zhang J, He M and Zhang J: Hyperoside pre-treatment prevents
glomerular basement membrane damage in diabetic nephropathy by
inhibiting podocyte heparanase expression. Sci Rep.
7(6413)2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Dai H, Liu Q and Liu B: Research progress
on mechanism of podocyte depletion in diabetic nephropathy. J
Diabetes Res. 2017(2615286)2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chagnac A, Zingerman B, Rozen-Zvi B and
Herman-Edelstein M: Consequences of glomerular hyperfiltration: The
role of physical forces in the pathogenesis of chronic kidney
disease in diabetes and obesity. Nephron. 143:38–42.
2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tsuchiya K: Inflammasome-associated cell
death: Pyroptosis, apoptosis, and physiological implications.
Microbiol Immunol. 64:252–269. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li X, Zeng L, Cao C, Lu C, Lian W, Han J,
Zhang X, Zhang J, Tang T and Li M: Long noncoding RNA MALAT1
regulates renal tubular epithelial pyroptosis by modulated miR-23c
targeting of ELAVL1 in diabetic nephropathy. Exp Cell Res.
350:327–335. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Petrica L, Ursoniu S, Gadalean F, Vlad A,
Gluhovschi G, Dumitrascu V, Vlad D, Gluhovschi C, Velciov S, Bob F,
et al: Urinary podocyte-associated mRNA levels correlate with
proximal tubule dysfunction in early diabetic nephropathy of type 2
diabetes mellitus. Diabetol Metab Syndr. 9(31)2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Cheng W, Meng W and Gu Y: Metalloprotease
Adam10 inhibition mitigates acute liver injury via repression of
intrahepatic inflammation. Minerva Med. 113:506–512.
2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang W, Lu F, Xie Y, Lin Y, Zhao T, Tao
S, Lai Z, Wei N, Yang R, Shao Y and He J: miR-23b negatively
regulates sepsis-induced inflammatory responses by targeting ADAM10
in human THP-1 monocytes. Mediators Inflamm.
2019(5306541)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Xu Y, Ma Y, Liu XL and Gao SL: miR-133b
affects cell proliferation, invasion and chemosensitivity in renal
cell carcinoma by inhibiting the ERK signaling pathway. Mol Med
Rep. 22:67–76. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Jiang QG, Xiong CF and Lv YX: Kin17
facilitates thyroid cancer cell proliferation, migration, and
invasion by activating p38 MAPK signaling pathway. Mol Cell
Biochem. 476:727–739. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang Y, Wang C, Zhang X, Gu HF and Wu L:
Common drugs for stabilization of renal function in the progression
of diabetic nephropathy and their relations with hypertension
therapy. Curr Diabetes Rev. 14:149–161. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Xiong Y and Zhou L: The signaling of
cellular senescence in diabetic nephropathy. Oxid Med Cell Longev.
2019(7495629)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tung CW, Hsu YC, Shih YH, Chang PJ and Lin
CL: Glomerular mesangial cell and podocyte injuries in diabetic
nephropathy. Nephrology (Carlton). 23 (Suppl 4):S32–S37.
2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Moreno JA, Gomez-Guerrero C, Mas S, Sanz
AB, Lorenzo O, Ruiz-Ortega M, Opazo L, Mezzano S and Egido J:
Targeting inflammation in diabetic nephropathy: A tale of hope.
Expert Opin Investig Drugs. 27:917–930. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
An X, Zhang Y, Cao Y, Chen J, Qin H and
Yang L: Punicalagin protects diabetic nephropathy by inhibiting
pyroptosis based on TXNIP/NLRP3 pathway. Nutrients.
12(1516)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Koka S, Xia M, Zhang C, Zhang Y, Li PL and
Boini KM: Podocyte NLRP3 inflammasome activation and formation by
Adipokine Visfatin. Cell Physiol Biochem. 53:355–365.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chen Y, Liu Q, Shan Z, Zhao Y, Li M, Wang
B, Zheng X and Feng W: The protective effect and mechanism of
catalpol on high glucose-induced podocyte injury. BMC Complement
Altern Med. 19(244)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chen L, Wang Y, Luan H, Ma G, Zhang H and
Chen G: DUSP6 protects murine podocytes from high glucose-induced
inflammation and apoptosis. Mol Med Rep. 22:2273–2282.
2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ramachandran RP, Spiegel C, Keren Y,
Danieli T, Melamed-Book N, Pal RR, Zlotkin-Rivkin E, Rosenshine I
and Aroeti B: Mitochondrial targeting of the enteropathogenic
escherichia coli map triggers calcium mobilization, ADAM10-MAP
kinase signaling, and host cell apoptosis. mBio. 11:e01397–e01320.
2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Park JH, Choi JY, Jo C and Koh YH:
Involvement of ADAM10 in acrolein-induced astrocytic inflammation.
Toxicol Lett. 318:44–49. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang FL, Zhou BW, Yan ZZ, Zhao J, Zhao
BC, Liu WF, Li C and Liu KX: 6-Gingerol attenuates macrophages
pyroptosis via the inhibition of MAPK signaling pathways and
predicts a good prognosis in sepsis. Cytokine.
125(154854)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chen XW, Liu WT, Wang YX, Chen WJ, Li HY,
Chen YH, Du XY, Peng FF, Zhou WD, Xu ZZ and Long HB:
Cyclopropanyldehydrocostunolide LJ attenuates high glucose-induced
podocyte injury by suppressing RANKL/RANK-mediated NF-κB and MAPK
signaling pathways. J Diabetes Complications. 30:760–769.
2016.PubMed/NCBI View Article : Google Scholar
|
